CTOs on the Move


 
Create the most delightful experiences for our guests. We believe we can positively change the way people think about alternative lodging. The process begins by seeking out high-quality homes with modern spaces and prime locations, to ensure our designers can bring out the natural beauty of each property and to give you an authentic travel experience. We deck out each Domio with curated furniture, accessories and artwork to create a distinguished level of style and comfort, and provide round-the-clock concierge services for your convenience. With Domio, feel at home anywhere in the world.
  • Number of Employees: 100-250
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

Domio raised $50M on 09/24/2018
Domio raised $12M on 10/19/2018
Domio raised $50M on 12/18/2019

Similar Companies

Blueprint Medicines

Blueprint Medicines is developing a new generation of highly selective and potent kinase therapies to dramatically improve the lives of patients with genomically defined diseases. Our approach is rooted in a deep understanding of the genetic blueprint of cancer and other diseases driven by the abnormal activation of kinases. Our ability to identify novel drivers of disease, coupled with our proprietary library of novel and diverse chemical compounds, uniquely enables us to craft kinase therapies against new and difficult-to-drug targets. We are boldly advancing a deep pipeline of highly targeted therapies against previously unaddressed drivers of disease. By focusing on genomically defined subsets of patients, we believe we can identify the people most likely to respond to our therapies, resulting in a more efficient clinical development path with a greater likelihood of success and better outcomes for patients. We see a substantial opportunity in kinase drug discovery and development to deliver breakthrough medicines that allow patients to live longer with better quality of life and prevent recurrences of disease. Kinases are involved in many hallmarks of tumor biology and are proven cancer drug targets. Currently approved drugs focus on less than 5 percent of known kinases, and the function of most kinases is unknown. Led by a team of industry innovators with a track record of bringing life-changing drugs to market, we believe Blueprint Medicines has the experience and expertise to deliver on the tremendous untapped potential of kinase therapies to improve patients’ lives. We don’t think in small steps. We think in giant leaps. We are driven by the pursuit of new ideas, new innovations, and new ways of thinking.

Alliance for Health Care Reform

Alliance for Health Care Reform is a Washington, DC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Occulogix

Occulogix, Inc. is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Occulogix, Inc. is based in Elliot Lake, ON. You can find more information on Occulogix, Inc. at www.occulogix.com

Bruce Valentine, DDS

Bruce Valentine, DDS is a Modesto, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

global healthcare associates inc

global healthcare associates inc is a Parsippany, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.